Furthermore, in Shh-subtype medulloblastoma, the TrkA high expression patient group corresponded to a lower overall survival rate in comparison with the low expression patient group (GSE85217 [46]) (Fig. 6C). This evidence concerns the gene SHH and medulloblastoma.